Method for preparing a stable TNF-α vaccine
US8372388B2 · kind B2 · utility
0Cited by
7References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2005 |
| Grant date | Feb 12, 2013 |
| Priority date | — |
| Expiry date | Aug 14, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/622
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A stable immunogenic product for the induction of antibodies against one or more antigenic proteins in a subject, characterized in that it comprises proteinaceous immunogenic heterocomplexes which are formed by associations between (i) antigenic protein molecules and (ii) proteinaceous carrier molecules and in that less than 40% of the antigenic proteins (i) are linked to the proteinaceous carrier molecules (ii) by a covalent bond.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.